Methods of use of chimerized, humanized, and single chain antibo

Details Methods of use of chimerized, humanized, and single chain antibo Methods of use of chimerized, humanized, and single chain antibo

1994-10-20

1998-11-24

Loring, Susan A.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

4241331, 4241351, 53038822, 5303873, 5303881, A61K 39395, C07K 1600, C12P 2108

Patent

active

058403019

ABSTRACT:
Monoclonal antibodies that specifically bind to an extracellular domain of a VEGF receptor and neutralize activation of the receptor are provided. In vitro and in vivo methods of using these antibodies are also provided.

REFERENCES:
patent: 5270458 (1993-12-01), Lemischka
Plate, et al., Nature 359, 845-848 (Oct. 1992).
Folkman, J. and Klagsbrun, M., Angiogenic Factors, Science 235: 442-447 (Jan. 23, 1987).
Kapainen et al., J. Exp. Med 178:2077-2088 (Dec. 1993).
Kim et al., Nature 362:841-844 (Apr. 29, 1993).
Matthews et al., PNAS USA 88:9026-9030 (Oct. 1991).
Millaur et al., Cell 72:835-846 (1993).
Plate et al., Cancer Research 53:5822-5827 (Dec. 1, 1993).
Shibuya et al., Oncogene 5:519-524 (1990).
Terman et al., Oncogene 6:1677-1683 (1991).
Kim, K.J. et al, Growth Factors, 7:53-64, 1992.
Morrison, S.L. et al, PNAS, 81:6851-6855, Nov. 1984.
Co, M.S. et al, Nature, 351:501-502, 1991.

Affiliated with

Also associated with

Rating

Methods of use of chimerized, humanized, and single chain antibo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of use of chimerized, humanized, and single chain antibo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of use of chimerized, humanized, and single chain antibo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1699164